End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
836.2 INR | +1.68% | -0.47% | +27.27% |
15/05 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
25/04 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.27% | 1.23B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- GLS Stock
- News Glenmark Life Sciences Limited
- Transcript : Glenmark Life Sciences Limited, Q3 2023 Earnings Call, Jan 27, 2023